{"result": "(\"entity\"<|>ADRENOLEUKODYSTROPHY<|>EVENT<|>Adrenoleukodystrophy is a genetic disorder characterized by the accumulation of very long-chain fatty acids due to a defect in the β-oxidation of fatty acids, leading to neurological symptoms and metabolic issues.)\n##\n(\"entity\"<|>GTO-GTE<|>ORGANIZATION<|>GTO-GTE refers to a combination of glycerol trioleate and glycerol trierucate, which may have therapeutic implications in the treatment of certain metabolic disorders.)\n##\n(\"entity\"<|>MÉDULA ÓSEA<|>ORGANIZATION<|>Médula ósea refers to bone marrow, which is used in transplants for patients with moderate neurological involvement in adrenoleukodystrophy.)\n##\n(\"entity\"<|>HIPOGLUCEMIA<|>EVENT<|>Hypoglycemia is a condition characterized by abnormally low blood sugar levels, which can be a symptom of metabolic disorders including adrenoleukodystrophy.)\n##\n(\"entity\"<|>MIOTAPÍA<|>EVENT<|>Miopatía refers to muscle disease, which can be a symptom associated with metabolic disorders like adrenoleukodystrophy.)\n##\n(\"entity\"<|>HEPATOPATÍA<|>EVENT<|>Hepatopatía refers to liver disease, which can also be a symptom associated with metabolic disorders like adrenoleukodystrophy.)\n##\n(\"entity\"<|>ARRITMIAS CARDÍACAS<|>EVENT<|>Arritmias cardíacas refer to heart rhythm disorders, which can occur as a symptom in patients with metabolic disorders such as adrenoleukodystrophy.)\n##\n(\"entity\"<|>DIETA RESTRICTIVA<|>EVENT<|>Dieta restrictiva refers to a dietary treatment aimed at managing symptoms of metabolic disorders by avoiding fasting and ensuring slow-absorbing carbohydrates.)\n##\n(\"relationship\"<|>ADRENOLEUKODYSTROPHY<|>GTO-GTE<|>The combination of GTO-GTE may help slow down neurological deterioration in patients with adrenoleukodystrophy<|>7)\n##\n(\"relationship\"<|>ADRENOLEUKODYSTROPHY<|>MÉDULA ÓSEA<|>Bone marrow transplants are used in the treatment of patients with moderate neurological involvement in adrenoleukodystrophy<|>8)\n##\n(\"relationship\"<|>ADRENOLEUKODYSTROPHY<|>HIPOGLUCEMIA<|>Hypoglycemia is a common symptom associated with adrenoleukodystrophy<|>6)\n##\n(\"relationship\"<|>ADRENOLEUKODYSTROPHY<|>MIOTAPÍA<|>Miopatía is a symptom that can occur in patients with adrenoleukodystrophy<|>6)\n##\n(\"relationship\"<|>ADRENOLEUKODYSTROPHY<|>HEPATOPATÍA<|>Hepatopatía is a symptom that can occur in patients with adrenoleukodystrophy<|>6)\n##\n(\"relationship\"<|>ADRENOLEUKODYSTROPHY<|>ARRITMIAS CARDÍACAS<|>Arritmias cardíacas can be a symptom in patients with adrenoleukodystrophy<|>6)\n##\n(\"relationship\"<|>ADRENOLEUKODYSTROPHY<|>DIETA RESTRICTIVA<|>A restrictive diet plays a crucial role in managing symptoms of adrenoleukodystrophy<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: de gliceril trioleato y gloceriltrierucato en                           dence for X-linkage, inactivation and selection fa-\nproporción 4:1), que consigue normalizar las concen-                               vouring the mutant allele in heterozygous cells.\ntraciones plasmáticas de ácidos grasos de cadena muy                               Proc Natl Acad Sci USA 1981; 78: 5066-5070.\nlarga. Los resultados clínicos no apoyan el uso de acei-                       5.  Gartner J, Braun A, Holzinger A, Roerig P, Lenard\nte de Lorenzo en pacientes con síntomas neurológicos                               HG, Roscher AA. Clinical and genetic aspects of\npreexistentes. No obstante, algunos estudios sugieren                              X-linked    adrenoleukodystrophy.           Neuropediatrics\nque la combinación GTO-GTE puede enlentecer el de-                                 1998; 29: 3-13.\nterioro neurológico de pacientes asintomáticos.                                6.  Moser HW. Clinical and therapeutic aspects of\n   Los intentos de modificar la respuesta inflamatoria                             adrenoleukodystrophy and adrenomyeloneuropa-\ncerebral utilizando agentes antiinflamatorios o inmu-                              thy. J Neuropathol Exp Neurol 1995; 54 (5): 740-\nnosupresores no han demostrado eficacia. Se ha utili-                              745.\nzado el trasplante de médula ósea en pacientes con                             7.  Powers JM. Adrenoleukodystrophy. Clin Neuropa-\nafectación neurológica moderada y donante compati-                                 thol 1985; 4: 181-199.\nble, con resultados reservados debido al alto riesgo del                       8.  Powers JM, Liu Y, Moser A, Moser H. The inflam-\ntrasplante.                                                                        matory     myelinopathy       of   adrenoleukodystrophy:\n   Los trastornos de la β-oxidación de los ácidos grasos                           cells, effector molecules and pathogenic implica-\nson metabolopatías que se heredan de forma autosómi-                               tion. J Neuropathol Exp Neurol 1992; 51: 630-\nca recesiva, y que en su mayor parte se caracterizan por                           643.\nhipoglucemia no cetósica, con mala tolerancia a los pe-                        9.  Igarashi M, Shaumburg HH, Powers J, Kishimoto\nríodos de ayuno. Otros síntomas que pueden acompa-                                 Y, Kolodny E, Suzuki K. Fatty acid abnormality in\nñar a estos trastornos metabólicos son miopatía, hepa-                             adrenoleukodystrophy. J Neurochem 1976; 26:\ntopatía, y en ocasiones neuropatía y arritmias cardíacas.                          851-860.\nEl tratamiento dietético juega un papel muy importante                       10.   Knazek RA, Rizzo WB, Schulman JD, Dave JR.\nen estos trastornos, y está dirigido a evitar los períodos                         Membrane microviscosity is increased in the eritro-\nde ayuno y asegurar el aporte de hidratos de carbono de                            cytes of patients with adrenoleukodystrophy and\nabsorción lenta, a la vez que se restringe cuantitativa y                          adrenomyeloneuropathy. J Clin Invest 1983; 72:\ncualitativamente las grasas de la dieta.                                           245-248.\n   Hay dos tipos fundamentales de trastornos de la                           11.   Kishimoto Y, Moser HW, Kawamura N, Platt M,\nβ-oxidación de los ácidos grasos: los que afectan a los                            Pallante B, Fenselau C. Evidence that abnormal\nácidos grasos de cadena larga y muy larga, y los que                               very long chain fatty acids of brain cholesterol es-\nafectan a ácidos grasos de cadena media. En el primer                              ters are of exogenous origin. Biochem Byophys Res\ncaso, debe garantizarse el aporte de ácidos grasos                                 Commun 1980; 96: 69-76.\nesenciales, y debe suplementarse la dieta con ácidos                         12.   Van Duyn MA, Moser AM, Brown FR, Sacktor N,\ngrasos de cadena media. En el déficit de β-oxidación                               Liu A, Moser HW. The design of a diet restricted in\nde los ácidos grasos de cadena media, la restricción                               saturated very long chain fatty acids: therapeutical\ncualitativa y cuantitativa de las grasas es más contro-                            application in adrenoleukodystrophy. Am J Clin\nvertida, y está contraindicado el uso de triglicéridos de                          Nutr 1984; 40: 277-284.\ncadena media.                                                                13.   Moser HW, Pallante SL, Moser AE, Rizzo WB, Shul-\n                                                                                   man J, Fenselau C. Adrenoleukod\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}